Nunn D L, Potter B V, Taylor C W
Department of Pharmacology, University of Cambridge, U.K.
Biochem J. 1990 Jan 15;265(2):393-8. doi: 10.1042/bj2650393.
Ins(1,4,5)P3 is the intracellular messenger that mediates the effects of many cell-surface receptors on intracellular Ca2+ stores. Although radioligand-binding studies have identified high-affinity Ins(1,4,5)P3-binding sites in many tissues, these have not yet been convincingly shown to be the receptors that mediate Ca2+ mobilization, nor is it clear whether there are differences in these binding sites between tissues. Here we report that Ins(1,4,5)P3 binds to a single class of high-affinity sites in both permeabilized hepatocytes (KD = 7.8 +/- 1.1 nM) and cerebellar membranes (KD = 6.5 +/- 2.4 nM), and provide evidence that these are unlikely to reflect binding to either of the enzymes known to metabolize Ins(1,4,5)P3. Furthermore, the rank order of potency of synthetic inositol phosphate analogues in displacing specifically bound Ins(1,4,5)P3 is the same as their rank order of potency in stimulating mobilization of intracellular Ca2+ stores, suggesting that the Ins(1,4,5)P3-binding site may be the physiological receptor. Radiation inactivation of the Ins(1,4,5)P3-binding sites of liver and cerebellum reveals that they have similar molecular target sizes: 257 +/- 36 kDa in liver and 258 +/- 20 kDa in cerebellum. We conclude that an Ins(1,4,5)P3-binding protein with a molecular target size of about 260 kDa is probably the receptor that mediates Ca2+ mobilization in hepatocytes, and our limited data provide no evidence to distinguish this from the cerebellar Ins(1,4,5)P3-binding protein.
肌醇-1,4,5-三磷酸(Ins(1,4,5)P3)是一种细胞内信使,介导许多细胞表面受体对细胞内钙库的作用。尽管放射性配体结合研究已在许多组织中鉴定出高亲和力的Ins(1,4,5)P3结合位点,但尚未令人信服地证明这些位点就是介导钙动员的受体,而且不同组织间这些结合位点是否存在差异也不清楚。在此我们报告,Ins(1,4,5)P3在通透的肝细胞(解离常数KD = 7.8±1.1 nM)和小脑膜(KD = 6.5±2.4 nM)中均与单一类别的高亲和力位点结合,并提供证据表明这些位点不太可能反映与已知代谢Ins(1,4,5)P3的任何一种酶的结合。此外,合成肌醇磷酸类似物在置换特异性结合的Ins(1,4,5)P3时的效力排序与其刺激细胞内钙库动员的效力排序相同,这表明Ins(1,4,5)P3结合位点可能是生理受体。对肝脏和小脑的Ins(1,4,5)P3结合位点进行辐射失活研究表明,它们具有相似的分子靶标大小:肝脏中为257±36 kDa,小脑中为258±20 kDa。我们得出结论,一种分子靶标大小约为260 kDa的Ins(1,4,5)P3结合蛋白可能是介导肝细胞中钙动员的受体,而我们有限的数据无法提供证据将其与小脑Ins(1,4,5)P3结合蛋白区分开来。